window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 15, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Research & Development

  • Clinical & Regulatory,Medical devices,Research & Development,Therapeutic Areas

    Alamar launches blood-based eMTBR-Tau assay for Alzheimer’s disease research

    Alamar Biosciences has launched what it describes as the first [...]

    July 8, 2026
  • Advanced Therapies,Manufacturing & Supply Chain,Medical devices,Research & Development

    Bio-Rad launches Vericheck ddPCR kits for cell and gene therapy quality control

    Bio-Rad Laboratories has launched a portfolio of Vericheck ddPCR kits [...]

    July 8, 2026
  • Advanced Therapies,Genomics and sequencing,Research & Development,Therapeutic Areas

    Genespire reports preclinical gene therapy data for methylmalonic acidemia

    Genespire and researchers at the San Raffaele Telethon Institute for [...]

    July 8, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    FORE Biotherapeutics completes enrolment in registrational plixorafenib brain tumour study

    FORE Biotherapeutics has completed target enrolment in the primary central [...]

    July 8, 2026
  • Clinical & Regulatory,Digital & Data,Research & Development

    Study quantifies financial benefits of risk-based quality management in oncology trials

    A peer-reviewed study published in Therapeutic Innovation & Regulatory Science [...]

    July 8, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Compass reports second positive Phase 3 trial of psilocybin therapy for treatment-resistant depression

    Compass Pathways has reported positive six-month results from its second [...]

    July 8, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Healome raises £2M to advance eye-drop technology for ocular surface diseases

    Healome Therapeutics has raised £2 million in seed funding to [...]

    July 8, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Research & Development,Therapeutic Areas

    EnteroBiotix doses first patient in Phase 2b IBS-C microbiome trial

    EnteroBiotix has dosed the first patient in its Phase 2b [...]

    July 7, 2026
  • Digital & Data,Drug Discovery & Development,Research & Development

    bit.bio launches cell culture media kits for human cell research

    bit.bio has launched two cell culture media kits designed to [...]

    July 6, 2026
  • Opinion & Events,Research & Development,Therapeutic Areas

    Halving fertility treatment costs could more than double ART births, study finds

    Reducing patient out-of-pocket fertility treatment costs by half could increase [...]

    July 7, 2026
Previous101112Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Jascayd approval expands treatment options for pulmonary fibrosis in Europe
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • National Health Council launches Detroit campaign to address kidney screening gap
    Categories: Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Enzene launches local biomanufacturing model to cut biologics manufacturing costs
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top